CPHI Trend Report - CDMO Opportunities in the Chinese Market

Opportunities for contract development and manufacturing organisations (CDMOs) in China continue to grow but many questions remain over what the future of the sector will look like in the world's second largest pharmaceutical market.
At present, there are three main areas driving CDMO opportunities in China: the recent rapid transformation of the country's healthcare sector, recent changes to its Drug Administration Law, and Chinese pharma companies' desire to tap into international markets.
CDMOs can be the logical bridge to this aspiration, given their expertise and experience in bringing products to the global market, where prices are often much more attractive than those in the Chinese domestic market.
Change is afoot in China, and via interviews with industry experts from BioPlan Associates, Biovane, Lonza and Vetter, this CPHI Trend Report seeks to explain how recent regulatory reform has impacted the pharmaceutical and biopharmaceutical contract services sector in the country and whether the government’s newfound emphasis on innovative products will transform how CDMOs are perceived in this complex but potentially lucrative market.



Related News
-
News 3 ways ChatGPT will impact pharma marketing teams
What does the rise of AI-powered chatbots such as ChatGPT and GPT-4 mean for pharma marketeers? -
News Innovation in Drug Delivery & Portfolio Renovation with Sofgen Pharmaceuticals
The Pharma industry is expected to reach $1.9Tn in revenue by 2027, increasing at a rate of 3-6% per year, according to IQVIA1, with some regions being driven by volume, and others by innovation. Growth in developed economies is projected to be slow, w... -
News Vetter joins United Nations Global Compact Network
Vetter (Ravensbury, Germany), the aseptic filling and packaging CDMO has signed up to the UN Global Compact Network. -
News Fully biodegradable nutraceutical packaging an industry first
An agreement signed between TricorBraun and BioBottles will give nutraceutical companies (and potentially pharmaceutical companies) in the US and Canada access to the industry’s first fully biodegradable packaging option. -
News Oxfordshire vaccine manufacturing site part of 10-year agreement between Moderna and UK government
In an effort to protect against potential future global health emergencies, the government of the UK and Moderna have cemented a 10-year partnership for vaccine manufacturing and research. -
Sponsored Content How healthcare trends inform dosage forms
Capsules encompass one of the most popular solid oral dosage forms for pharmaceutical products, with the global empty capsule market predicted to rise to USD $3.7 billion by 2026. The growth in the capsule market can be partly attributed to the many op... -
News Women in Pharma – Sukhada Chaturvedi Pharmapack 2023
This year at Pharmapack 2023, we interviewed several leading women in the pharmaceutical industry about what it means to be a woman working in pharma. In the lead-up to International Women’s Day on March 8, 2023, CPHI Online is proud to highlight... -
News 100 years of pharmaceutical packaging excellence - Pharmapack 2023 Premium Partner interview
West Pharmaceutical Services, Inc. speaks to CPHI Online about celebrating their 100-year anniversary as an industry leader, and how they plan to continue driving innovation after the challenges posed from global disruptions in the last few years.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance